| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/31/2006 | EP1660514A2 A novel gene and protein associated with angiogenesis and endothelial apoptosis |
| 05/31/2006 | EP1660513A2 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 05/31/2006 | EP1660136A2 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 05/31/2006 | EP1660135A1 Method of treating hepatocellular carcinoma |
| 05/31/2006 | EP1660128A2 Anti-fcrn antibodies for treatment of auto/allo immune conditions |
| 05/31/2006 | EP1660127A1 Antibodies to c-met |
| 05/31/2006 | EP1660125A1 Composition for the prophylaxis/treatment of hbv infections and hbv-mediated diseases |
| 05/31/2006 | EP1660124A2 Antigenic peptides of rabies virus and uses thereof |
| 05/31/2006 | EP1660123A2 Rotavirus vaccine |
| 05/31/2006 | EP1660122A2 Immunostimulatory combinations and treatments |
| 05/31/2006 | EP1660121A2 Live attenuated bacterial vaccine |
| 05/31/2006 | EP1660120A1 Live attenuated aldolase-negative bacterial vaccine |
| 05/31/2006 | EP1660119A2 Multi-antigen vectors for melanoma |
| 05/31/2006 | EP1660118A2 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
| 05/31/2006 | EP1660110A2 Therapeutic vaccine compositions for the treatment of type 1 diabetes |
| 05/31/2006 | EP1660094A2 Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections |
| 05/31/2006 | EP1660057A2 Combination therapy for the treatment of ocular neovascular disorders |
| 05/31/2006 | EP1660040A1 In vivo targeting of dendritic cells |
| 05/31/2006 | EP1660016A2 Sars nucleic acids, proteins, vaccines, and uses thereof |
| 05/31/2006 | EP1660010A2 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 05/31/2006 | EP1659918A2 Antibodies directed to parathyroid hormone (pth) and uses thereof |
| 05/31/2006 | EP1248641B1 Use of emap ii receptor antagonist composition for treating pulmonary hypertension |
| 05/31/2006 | EP1231270B1 Novel protein and dna thereof |
| 05/31/2006 | EP1212084B1 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 05/31/2006 | EP1198580B1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 05/31/2006 | EP1171454B1 Chimeric lyssavirus nucleic acids and polypeptides |
| 05/31/2006 | EP1165110B1 Antagonists of hmg1 for treating inflammatory conditions |
| 05/31/2006 | EP1115426B1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 05/31/2006 | EP1108014B1 Ehrlichia canis protein |
| 05/31/2006 | EP1073682B1 Heparanase specific molecular probes and their use in research and medical applications |
| 05/31/2006 | EP0914437B1 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 05/31/2006 | EP0911342B1 Novel protein and process for producing the same |
| 05/31/2006 | EP0888456B1 Prostate specific antigen oligo-epitope peptide |
| 05/31/2006 | EP0840789B1 Transketolase-related protein |
| 05/31/2006 | EP0757717B1 Papillomavirus vaccines |
| 05/31/2006 | EP0689593B1 Inhibition of selected tumor growth with recombinant viral vector |
| 05/31/2006 | CN1780919A Methods and products based on oligomerization of stress proteins |
| 05/31/2006 | CN1780916A Chicken RNA polymerisate I promoter and the use thereof |
| 05/31/2006 | CN1780911A Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
| 05/31/2006 | CN1780907A Anti-CCR5 antibody |
| 05/31/2006 | CN1780856A Human antibodies specific for interleukin 15 (IL-15) |
| 05/31/2006 | CN1780855A Human IL-1 beta antagonists |
| 05/31/2006 | CN1780852A Group 1 mite polypeptide variants |
| 05/31/2006 | CN1780850A Use of lectins to promote oligomerization of glycoproteins and antigenic molecules |
| 05/31/2006 | CN1780641A Single chain antigen-binding polypeptides for polymer conjugation |
| 05/31/2006 | CN1780640A Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 05/31/2006 | CN1780607A Zinc-containing sustained-release composition, its preparation, and method for producing the same |
| 05/31/2006 | CN1778926A Modified pig propagation and respiratory syndrome virus ORF5 gene and use thereof |
| 05/31/2006 | CN1778822A Monoclonal antibody of C-shaped agglutinin receptor L1, its production and use thereof |
| 05/31/2006 | CN1778816A Human cell surface membrane molecule and use thereof |
| 05/31/2006 | CN1778812A Nolvac viral coat protein with recombinant rod virus expression and its preparation |
| 05/31/2006 | CN1778389A Medicine for treating tumor and use thereof |
| 05/31/2006 | CN1778388A Young schistosomiasis cell style vaccine for preventing from schistosomiasis disease |
| 05/31/2006 | CN1257976C Improved vaccines |
| 05/31/2006 | CN1257973C Broad spectrum infectious chicken blader disease virus vaccine |
| 05/31/2006 | CN1257749C Sheep lamb increasing essence |
| 05/30/2006 | US7053186 Protein for use in diagnosis and treatment of cancer |
| 05/30/2006 | US7053181 Canine and feline B7-2 proteins, compositions and uses thereof |
| 05/30/2006 | US7053179 Inhibits hiv infection of cells |
| 05/30/2006 | US7053175 Delta -Z-TrpGlyCys- Theta -CysTyrThrSer- Omega, ( Delta represents a biotinyl radical, a biocytinyl radical, a hydrogen atom, an acetyl (CH3CO ) radical, an aliphatic chain which may contain one or two thiol, aldehyde or amine functional groups, and Z= a peptide sequence) |
| 05/30/2006 | US7053050 administering erythropoietin receptor antagonist or mimetics thereof |
| 05/30/2006 | US7052910 Generation of insulin- resistance in myotubes and screening and identification of physiologically active materials, capable of modulating the insulin receptor tyrosine phosphorylation and insulin receptor signal transduction |
| 05/30/2006 | US7052899 Toxoplasma gondii proteins, nucleic acid molecules, and uses thereof |
| 05/30/2006 | US7052872 Bi-specific antibodies for pre-targeting diagnosis and therapy |
| 05/30/2006 | US7052862 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 05/30/2006 | US7052860 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/30/2006 | US7052832 Determining sensitivity of a cell to reovirus infection; obtain cells, monitor ras protein signaling, consistent signaling indicates sensitivity to reovirus infection |
| 05/30/2006 | US7052830 diagnosing infection by way of binding an antibody or antigen reading frame then translating open; vaccines |
| 05/30/2006 | US7052705 Useful to control pathological angiogenesis, such as occurs in cancer and other diseases |
| 05/30/2006 | US7052704 Comprises fatty acid-conjugated products with disulfide linkage to proteins/peptides for delivery to cells; increases absorption and prolongs blood and tissue retention |
| 05/30/2006 | US7052703 T-cell receptorγ alternate reading frame protein, (TARP) and uses thereof |
| 05/30/2006 | US7052701 Inactivated influenza virus vaccine for nasal or oral application |
| 05/30/2006 | US7052699 Immunogenic composition |
| 05/30/2006 | US7052698 Surface proteins of Leptospira |
| 05/30/2006 | US7052697 immunogenic component stimulates antibody production in avian and/or pocine animals; gastrointestinal disorders |
| 05/30/2006 | US7052696 Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins |
| 05/30/2006 | US7052695 Angiopoietins and methods of treating hypertension |
| 05/30/2006 | US7052694 Immunoglobulin which specifically binds cell surface protein of nervous system tissue for preventing infections and treating tumors; anticarcinogenic agents; bactericides |
| 05/30/2006 | US7052693 Anti-human VEGF receptor FLT-1 monoclonal antibody |
| 05/30/2006 | US7052692 increasing transcription via inhibition of D-sequence-binding protein (D-BP), which is phosphorylated at tyrosine residues for blocking Adeno-mediated transgene expression in infected cells; inhibiting protein kinase activity; cancer treatment |
| 05/30/2006 | US7052689 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2006 | US7052675 binding antibody to substrate; neutralization of infection prions; in vivo diagnosis testing |
| 05/30/2006 | US7052674 Prokineticin polypeptides, related compositions and methods |
| 05/30/2006 | CA2288970C Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration |
| 05/30/2006 | CA2087525C Adoptive immunotherapy with interleukin-7 |
| 05/30/2006 | CA2005311C Prototype felv isolates for use in disease models and vaccines |
| 05/26/2006 | WO2006055886A2 Method for customized dispensing of variable dose drug combination products for individualizing of therapies |
| 05/26/2006 | WO2006055778A2 Immunoglobulin variable region cassette exchange |
| 05/26/2006 | WO2006055729A1 Iontophoretic device and method for administering immune response-enhancing agents and compositions |
| 05/26/2006 | WO2006055697A2 Cancer immunotherapy incorporating p53 |
| 05/26/2006 | WO2006055638A2 Fully human monoclonal antibodies to il-13 |
| 05/26/2006 | WO2006055331A2 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 05/26/2006 | WO2006055178A2 Anti-addl antibodies and uses thereof |
| 05/26/2006 | WO2006055024A2 Minicells as vaccines |
| 05/26/2006 | WO2006054748A1 Remedy for nephritis |
| 05/26/2006 | WO2006054059A1 Neutralising antibody molecules having specificity for human il-17 |
| 05/26/2006 | WO2006053883A1 Fibronectin iii domain as leptin receptor antagonists |
| 05/26/2006 | WO2006053871A2 Multivalent vaccines comprising recombinant viral vectors |
| 05/26/2006 | WO2006053861A1 Oligonucleotides that induce the secretion of gm-csf |
| 05/26/2006 | WO2006053485A1 A chimeric mycobacterium tuberculosis gene vaccine and the preparation method thereof |